Answer
Qarziba (dinutuximab beta) must be diluted aseptically to the patient-specific concentration/dose with sodium chloride 9 mg/mL (0.9%) solution for infusion containing 1% human albumin, protecting the solution from direct sunlight and heat.
Sources for this answer
- Qarziba (Dinutuximab beta)Recordati UK Ltd · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 13Document updated
Sources checked